Bacil Pharma Limited (BOM:524516)

India · Delayed Price · Currency is INR

21.85

-1.14 (-4.96%)

At close: Jul 31, 2026

Bacil Pharma Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Profit	-	-	-	-	-	-
Operating Income	-2.45	-2.45	-2.53	-1.89	-1.8	-1.59
Net Income	15.56	15.56	4.04	-0.59	-1.02	-38.6
Earnings Per Share	1.11	1.11	0.64	-0.10	-0.17	-6.55
EPS Growth	73.44%	73.44%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	5.69	5.69	28.57	0.41	2.2	3.06
Total Debt	-	-	1.64	0.98	0.21	0.33
Net Cash (Debt)	5.69	5.69	26.93	-0.57	1.99	2.73
Net Cash Growth	-78.89%	-78.89%	-	-	-27.11%	338.69%
Net Cash Per Share	0.41	0.41	4.27	-0.10	0.33	0.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	7.12	7.12	4.01	-0.03	-1.48	-40.09
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	7.12	7.12	4.01	-0.03	-1.48	-40.09
Free Cash Flow Growth	77.55%	77.55%	-	-	-	-

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	19.68	44.04	150.92	-	-	-
P/FCF Ratio	44.07	96.27	152.16	-	-	-